|
Mr. Jacques Rejeange joined the board of directors of POZEN in February of 2007 and is a member of the nominating/corporate governance committee.
Mr. Rejeange was previously appointed to the POZEN Board of Directors in April 1997 and served as Chairman of the Board of Directors from December 1999 to December 2000 before his retirement in 2004. He currently sits on the Boards of Medicentrix AG and Swisslog AG in Switzerland. Previously Mr. Rejeange was President of Florham Consulting S.A. based in Areuse Switzerland; Chief Operating Officer and later President and Chief Executive Officer of Sterling Winthrop Inc.; and President and Chief Executive Officer of Sandoz Pharmaceuticals Corporation USA. | 